Back to search

Article

Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwide

2020-09-06

Abstract excerpt

<h4>Background</h4> The SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is a positive-sense single-stranded RNA coronavirus responsible for the ongoing 2019-2020 COVID-19 outbreak. The highly contagious COVID-19 disease has spread to 216 countries in less than six months. Though several vaccine candidates are being claimed, an effective vaccine is yet to come. In present study we have designed and th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8df5e156-9f79-5e41-b5fb-fae078c743f7
DOI
10.1101/2020.09.06.284992
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwideDOI 10.1101/2020.09.06.284992
Epitope-based peptide vaccine design and target site characterization against novel coronavirus disease caused by SARS-CoV-2Semantic proximity
Novel ‘GaEl antigenic patches’ identified by ‘reverse epitomics’ approach to design multi-patch vaccines against NIPAH infection, a silent threat to global human healthSemantic proximity
Scrutinizing the SARS-CoV-2 protein information for the designing an effective vaccine encompassing both the T-cell and B-cell epitopesSemantic proximity
Structural Basis for Designing Multiepitope Vaccines Against COVID-19 Infection: In Silico Vaccine Design and ValidationSemantic proximity
Structural basis to design multi-epitope vaccines against Novel Coronavirus 19 (COVID19) infection, the ongoing pandemic emergency: an in silico approachSemantic proximity
Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approachSemantic proximity
A human-informed multi-patch T-cell vaccine induces broad CD8⁺ immunity and protects against SARS-CoV-2 infectionSemantic proximity
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approachSemantic proximity
Pangenome analysis of SARS-CoV2 strains to Identify Potential vaccine targets by Reverse VaccinologySemantic proximity
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an <i>in silico</i> approachSemantic proximity
Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics ApproachSemantic proximity
Immunogenic SARS-CoV-2 Epitopes: In Silico Study Towards Better Understanding of COVID-19 Disease—Paving the Way for Vaccine DevelopmentSemantic proximity
Select a neighboring publication to make it the new centre.